SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Aug 29, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its FY2026 report, ASPEN AEROGELS INC reported total assets of $392.9M, stockholders' equity of $192.5M, and revenue of $49.8M. Every figure below is taken directly from ASPEN AEROGELS INC's SEC filings: each links to the source document on EDGAR.
Revenue · FY2016–FY2025 · as reported
as of Jun 30, 2026 · 10-Q
10-Q (quarterly) · period ended Jun 30, 2026
| Revenue | $49.8M | Revenue | source ↗ |
| Net Income | -$23.3M | Net | source ↗ |
| Operating Income | -$28.8M | Operating | source ↗ |
| Gross Profit | $3.3M | Gross | source ↗ |
| Cost of Revenue | $46.6M | Cost | source ↗ |
| R&D Expense | $3.2M | Research | source ↗ |
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $-0.28 | Earnings | source ↗ |
| EPS (basic) | $-0.28 | Earnings | source ↗ |
| Shares Outstanding | 83.0M | Entity | source ↗ |
| Cash from Operations | -$16.2M | Net | source ↗ |
| Cash from Financing | -$4.2M | Net | source ↗ |
| Cash from Investing | -$1.8M | Net | source ↗ |
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
No material restatements detected across 358annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail behind the counts above, plus MCP access for your own agents, across the whole SEC universe.
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.